Year |
Citation |
Score |
2019 |
Younis US, Fazel M, Myrdal PB. Characterization of Tetracycline Hydrochloride Compounded in a Miracle Mouthwash Formulation. Aaps Pharmscitech. 20: 178. PMID 31041553 DOI: 10.1208/S12249-019-1388-X |
0.351 |
|
2019 |
Vallorz E, Sheth P, Myrdal P. Pressurized Metered Dose Inhaler Technology: Manufacturing. Aaps Pharmscitech. 20: 177. PMID 31037395 DOI: 10.1208/S12249-019-1389-9 |
0.6 |
|
2019 |
Younis US, Vallorz E, Addison KJ, Ledford JG, Myrdal PB. Preformulation and Evaluation of Tofacitinib as a Therapeutic Treatment for Asthma. Aaps Pharmscitech. 20: 167. PMID 30993508 DOI: 10.1208/S12249-019-1377-0 |
0.37 |
|
2017 |
Sheth P, Grimes MR, Stein SW, Myrdal PB. Impact of Droplet Evaporation Rate on Resulting In Vitro Performance Parameters of Pressurized Metered Dose Inhalers. International Journal of Pharmaceutics. PMID 28599855 DOI: 10.1016/J.Ijpharm.2017.06.014 |
0.676 |
|
2016 |
Johnson JL, Guthrie D, Hyde J, Hanson T, Karlage K, Myrdal PB. The effect of a holding chamber on albuterol metered-dose inhaler product differences. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 117: 246-50. PMID 27613457 DOI: 10.1016/J.Anai.2016.07.016 |
0.349 |
|
2016 |
Franklin SJ, Younis US, Myrdal PB. Estimating the Aqueous Solubility of Pharmaceutical Hydrates. Journal of Pharmaceutical Sciences. 105: 1914-9. PMID 27238488 DOI: 10.1016/J.Xphs.2016.03.040 |
0.327 |
|
2016 |
Aodah A, Pavlik A, Karlage K, Myrdal PB. Preformulation Studies on Piperlongumine. Plos One. 11: e0151707. PMID 26982320 DOI: 10.1371/Journal.Pone.0151707 |
0.36 |
|
2015 |
Stein SW, Sheth P, Younis US, Mogalian E, Myrdal PB. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs. Molecular Pharmaceutics. PMID 26258647 DOI: 10.1021/Acs.Molpharmaceut.5B00467 |
0.789 |
|
2015 |
Franklin SJ, Myrdal PB. Solid-State and Solution Characterization of Myricetin. Aaps Pharmscitech. 16: 1400-8. PMID 25986594 DOI: 10.1208/S12249-015-0329-6 |
0.377 |
|
2015 |
Sheth P, Stein SW, Myrdal PB. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers. Aaps Pharmscitech. 16: 192-201. PMID 25273026 DOI: 10.1208/S12249-014-0210-Z |
0.672 |
|
2014 |
Sheth P, Bertsch MD, Knapp CL, Myrdal PB. In vitro evaluation of nonconventional accessory devices for pressurized metered-dose inhalers. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 113: 55-62. PMID 24814758 DOI: 10.1016/J.Anai.2014.04.006 |
0.578 |
|
2014 |
Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. Aaps Pharmscitech. 15: 434-55. PMID 24452499 DOI: 10.1208/S12249-013-0063-X |
0.665 |
|
2014 |
Stein SW, Sheth P, Hodson PD, Myrdal PB. Advances in metered dose inhaler technology: hardware development. Aaps Pharmscitech. 15: 326-38. PMID 24357110 DOI: 10.1208/S12249-013-0062-Y |
0.627 |
|
2014 |
Franklin SJ, Dickinson SE, Karlage KL, Bowden GT, Myrdal PB. Stability of sulforaphane for topical formulation. Drug Development and Industrial Pharmacy. 40: 494-502. PMID 23611476 DOI: 10.3109/03639045.2013.768634 |
0.304 |
|
2013 |
Sheth P, Stein SW, Myrdal PB. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers International Journal of Pharmaceutics. 455: 57-65. PMID 23911912 DOI: 10.1016/J.Ijpharm.2013.07.061 |
0.684 |
|
2012 |
Karlage KL, Franklin SJ, Mufich WC, Goetz KJ, Sabelka JV, Hoye WL, Myrdal PB. Comparative evaluation of pharmaceutical products obtained in Mexico: augmenting existing scientific data. Drug Development and Industrial Pharmacy. 38: 808-14. PMID 22091930 DOI: 10.3109/03639045.2011.628678 |
0.737 |
|
2012 |
Stein SW, Sheth P, Myrdal PB. A model for predicting size distributions delivered from pMDIs with suspended drug International Journal of Pharmaceutics. 422: 101-115. PMID 22044537 DOI: 10.1016/J.Ijpharm.2011.10.035 |
0.648 |
|
2010 |
Guo D, Myrdal PB, Karlage KL, O'Connell SP, Wissinger TJ, Tabibi SE, Yalkowsky SH. Stability of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in combination. Aaps Pharmscitech. 11: 247-52. PMID 20151336 DOI: 10.1208/S12249-010-9383-2 |
0.351 |
|
2010 |
Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, et al. A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 160-9. PMID 20103724 DOI: 10.1158/1940-6207.Capr-09-0183 |
0.303 |
|
2010 |
Karlage KL, Mogalian E, Jensen A, Myrdal PB. Inhalation of an ethanol-based zileuton formulation provides a reduction of pulmonary adenomas in the A/J mouse model. Aaps Pharmscitech. 11: 168-73. PMID 20101484 DOI: 10.1208/S12249-009-9371-6 |
0.728 |
|
2009 |
Kuehl PJ, Stratton SP, Powell MB, Myrdal PB. Preformulation, formulation, and in vivo efficacy of topically applied apomine. International Journal of Pharmaceutics. 382: 104-10. PMID 19699284 DOI: 10.1016/J.Ijpharm.2009.08.016 |
0.679 |
|
2009 |
Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. Journal of Managed Care Pharmacy : Jmcp. 15: 253-61. PMID 19326956 DOI: 10.18553/Jmcp.2009.15.3.253 |
0.316 |
|
2009 |
Sanghvi R, Mogalian E, Machatha SG, Narazaki R, Karlage KL, Jain P, Tabibi SE, Glaze E, Myrdal PB, Yalkowsky SH. Preformulation and pharmacokinetic studies on antalarmin: a novel stress inhibitor. Journal of Pharmaceutical Sciences. 98: 205-14. PMID 18428980 DOI: 10.1002/Jps.21421 |
0.744 |
|
2008 |
Mogalian E, Sepassi K, Myrdal PB. Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers. Drug Development and Industrial Pharmacy. 34: 930-5. PMID 18800253 DOI: 10.1080/03639040802154871 |
0.721 |
|
2008 |
Hoye JA, Myrdal PB. Measurement and correlation of solute solubility in HFA-134a/ethanol systems. International Journal of Pharmaceutics. 362: 184-8. PMID 18647644 DOI: 10.1016/J.Ijpharm.2008.06.020 |
0.762 |
|
2008 |
Kuehl PJ, Brenner T, Jain PK, Karlage K, Sepassi K, Yang G, Mayersohn M, Yalkowsky SH, Myrdal PB. Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations. Journal of Pharmaceutical Sciences. 97: 5222-8. PMID 18383335 DOI: 10.1002/Jps.21384 |
0.689 |
|
2008 |
Hoye JA, Gupta A, Myrdal PB. Solubility of solid solutes in HFA-134a with a correlation to physico-chemical properties. Journal of Pharmaceutical Sciences. 97: 198-208. PMID 17828733 DOI: 10.1002/Jps.21080 |
0.765 |
|
2007 |
Mogalian E, Kuehl PJ, Myrdal PB. New analytical techniques to facilitate preformulation screening in propellant systems. International Journal of Pharmaceutics. 340: 223-9. PMID 17498897 DOI: 10.1016/J.Ijpharm.2007.03.026 |
0.776 |
|
2007 |
Myrdal PB, Karlage K, Kuehl PJ, Angersbach BS, Merrill BA, Wightman PD. Effects of novel 5-lipoxygenase inhibitors on the incidence of pulmonary adenomas in the A/J murine model when administered via nose-only inhalation. Carcinogenesis. 28: 957-61. PMID 17114645 DOI: 10.1093/Carcin/Bgl216 |
0.663 |
|
2006 |
Harris JA, Stein SW, Myrdal PB. Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers. Aaps Pharmscitech. 7: E138-E145. PMID 28290035 DOI: 10.1208/Pt070120 |
0.402 |
|
2006 |
Myrdal PB, Mogalian E, Mitchell J, Nagel M, Wright C, Kiser B, Prell M, Woessner M, Stein SW. Application of heated inlet extensions to the TSI 3306/3321 system: comparison with the Andersen cascade impactor and next generation impactor. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 19: 543-54. PMID 17196082 DOI: 10.1089/Jam.2006.19.543 |
0.731 |
|
2006 |
Myrdal PB, Angersbach BS, Karlage K, Kuehl PJ. Chiral separation of lipoxygenase metabolites utilizing high-performance liquid chromatography. Journal of Chromatography. A. 1132: 315-9. PMID 17005188 DOI: 10.1016/J.Chroma.2006.07.010 |
0.612 |
|
2006 |
Kuehl PJ, Hoye WL, Myrdal PB. Preformulation studies on imexon. Drug Development and Industrial Pharmacy. 32: 687-97. PMID 16885124 DOI: 10.1080/03639040600599830 |
0.734 |
|
2006 |
Kuehl PJ, Angersbach BS, Stratton SP, Myrdal PB. Development of an HPLC method for the analysis of Apomine in a topical cream formulation. Journal of Pharmaceutical and Biomedical Analysis. 40: 975-80. PMID 16181759 DOI: 10.1016/J.Jpba.2005.07.046 |
0.637 |
|
2006 |
Harris JA, Stein SW, Myrdal PB. Erratum: Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers (AAPS PharmaSciTech) Aaps Pharmscitech. 7. DOI: 10.1208/Pt070381 |
0.355 |
|
2006 |
Kuehl PJ, Carducci MD, Myrdal PB. 4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one Acta Crystallographica Section E Structure Reports Online. 62: o3688-o3690. DOI: 10.1107/S1600536806029412 |
0.62 |
|
2006 |
Stein SW, Myrdal PB. The Relative Influence of Atomization and Evaporation on Metered Dose Inhaler Drug Delivery Efficiency Aerosol Science and Technology. 40: 335-347. DOI: 10.1080/02786820600612268 |
0.373 |
|
2005 |
Karlage KL, Myrdal PB. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study. Drug Development and Industrial Pharmacy. 31: 993-1000. PMID 16316855 DOI: 10.1080/03639040500306245 |
0.319 |
|
2005 |
Mogalian E, Myrdal PB. Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers. Drug Development and Industrial Pharmacy. 31: 977-85. PMID 16316853 DOI: 10.1080/03639040500306211 |
0.761 |
|
2005 |
Hoye WL, Mogalian EM, Myrdal PB. Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 62: 2271-7. PMID 16239418 DOI: 10.2146/Ajhp050067 |
0.738 |
|
2005 |
Gupta A, Myrdal PB. A comparison of two methods to determine the solubility of compounds in aerosol propellants. International Journal of Pharmaceutics. 292: 201-9. PMID 15725567 DOI: 10.1016/J.Ijpharm.2005.01.001 |
0.338 |
|
2004 |
Myrdal PB, Stein SW, Mogalian E, Hoye W, Gupta A. Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: solution metered dose inhalers. Drug Development and Industrial Pharmacy. 30: 859-68. PMID 15521331 DOI: 10.1081/Ddc-200034575 |
0.757 |
|
2004 |
Gupta A, Myrdal PB. Novel method for the determination of solubility in aerosol propellants. Journal of Pharmaceutical Sciences. 93: 2411-9. PMID 15349951 DOI: 10.1002/Jps.20154 |
0.37 |
|
2004 |
Stein SW, Myrdal PB. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. Journal of Pharmaceutical Sciences. 93: 2158-75. PMID 15236462 DOI: 10.1002/Jps.20116 |
0.336 |
|
2004 |
Gupta A, Myrdal PB. On-line high-performance liquid chromatography method for analyte quantitation from pressurized metered dose inhalers. Journal of Chromatography. A. 1033: 101-6. PMID 15072294 DOI: 10.1016/J.Chroma.2004.01.034 |
0.36 |
|
2004 |
Myrdal PB, Karlage KL, Stein SW, Brown BA, Haynes A. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers. Journal of Pharmaceutical Sciences. 93: 1054-61. PMID 14999741 DOI: 10.1002/Jps.20025 |
0.417 |
|
2004 |
Gupta A, Myrdal PB. Development of a perillyl alcohol topical cream formulation. International Journal of Pharmaceutics. 269: 373-83. PMID 14706249 DOI: 10.1016/J.Ijpharm.2003.09.026 |
0.364 |
|
2003 |
Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 16: 167-74. PMID 12823910 DOI: 10.1089/089426803321919924 |
0.408 |
|
2003 |
Stein SW, Myrdal PB, Gabrio BJ, Obereit D, Beck TJ. Evaluation of a new Aerodynamic Particle Sizer Spectrometer for size distribution measurements of solution metered dose inhalers. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 16: 107-19. PMID 12823905 DOI: 10.1089/089426803321919870 |
0.327 |
|
2003 |
Kuehl PJ, Carducci MD, Myrdal PB. An ethanol solvate of Beclomethasone dipropionate Acta Crystallographica Section E Structure Reports Online. 59: o1888-o1890. DOI: 10.1107/S1600536803024425 |
0.643 |
|
1995 |
Myrdal PB, Simamora P, Surakitbanharn Y, Yalkowsky SH. Studies in phlebitis. VII: In vitro and in vivo evaluation of pH‐solubilized levemopamil Journal of Pharmaceutical Sciences. 84: 849-852. PMID 7562436 DOI: 10.1002/Jps.2600840713 |
0.39 |
|
Show low-probability matches. |